DAPAGLIFLOZIN C2 EPIMER
UNII WK33WFE47M

Substance Identification & Data

This profile provides standardized clinical and technical data for Dapagliflozin C2 Epimer, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WK33WFE47M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2133407-75-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WK33WFE47M

CAS Registry Number

2133407-75-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAPAGLIFLOZIN C2 EPIMER

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H25ClO6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JVHXJTBJCFBINQ-MJCUULBUSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

57519518

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]1([C@H]([C@@H]([C@@H]([C@H](c2cc(c(cc2)Cl)Cc3ccc(OCC)cc3)O1)O)O)O)CO

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dapagliflozin C2 Epimer. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.